News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Conference News AHA 2019 Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS Todd Neale November 20, 2019
News Daily News Elderly Women Worse Off Than Men Before and After Acute MI Yael L. Maxwell October 22, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2019 Shelley Wood October 01, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019
News Conference News ESC 2019 Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2 Todd Neale September 04, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News Stroke After PCI: Rare but Rising as Patient Complexity Climbs Todd Neale August 05, 2019
News Daily News Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery Michael O'Riordan July 29, 2019
News Daily News Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk Marcus A. Banks July 24, 2019
News Daily News Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI? Michael O'Riordan July 03, 2019
News Conference News EuroPCR 2019 Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study Caitlin E. Cox June 05, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Daily News Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study Michael O'Riordan April 24, 2019
News Daily News Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks Michael O'Riordan April 10, 2019
News Conference News ACC 2019 No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel Shelley Wood March 19, 2019
Presentation ACC 2019 Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial Presenter: Renato Lopes March 18, 2019
News Conference News ACC 2019 AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI Caitlin E. Cox March 17, 2019
News Daily News In-Hospital Acute MI: Despite Numerous Predictors, Solutions Remain Elusive Caitlin E. Cox January 18, 2019
News Daily News Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection Todd Neale January 18, 2019